BioSpace News Archive

Job Trends

IZERVAY™ (avacincaptad pegol intravitreal solution) Monthly or Every Other Month Reduced Geographic Atrophy Lesion Growth Through 2 Years

Astellas Pharma Inc. announced results from the GATHER2 Phase 3 clinical trial, demonstrating IZERVAY™ continued to reduce the rate of geographic atrophy lesion growth for both every month and every-other-month dosing vs. sham through 2 years of treatment in patients with GA secondary to age-related macular degeneration.

November 4, 2023
·
8 min read
Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capability of its proprietary E2E Platform to generate multiple enhanced TCR-T therapies against mKRAS G12V A*11

Medigene AG presents novel preclinical data of their MDG2011 program lead candidates which are optimal affinity Kirsten rat sarcoma viral oncogene homologue mutation -specific T cell receptors targeting human leukocyte antigens A*11, in combination with a PD1-41BB costimulatory switch protein at the Society for Immunotherapy of Cancer 2023 November 1-5, 2023, in San Diego, USA.

November 4, 2023
·
8 min read
BioCapital

Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study

Boehringer Ingelheim and Carelon Research have conducted a validation study of the Klinrisk model, a machine-learning tool developed to predict the risk of chronic kidney disease progression at all stages of the disease.

November 4, 2023
·
4 min read